Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Manning

Showing results (921-930 of 1,030) with videos related to

Pageof 103
Sort By:
Drug Testing and Analysis|March 7, 2019
The chemistry and pharmacology of putative synthetic cannabinoid receptor agonist (SCRA) new psychoactive substances (NPS) 5F-PY-PICA, 5F-PY-PINACA, and their analogsSamuel D Banister, Richard C Kevin, Lewis Martin, et al.
Journal of the American College of Cardiology|April 5, 2008
Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonanceA Selcuk Adabag, Barry J Maron, Evan Appelbaum, et al.
Surgical Infections|January 26, 2006
The effect of antipyretic therapy upon outcomes in critically ill patients: a randomized, prospective studyCarl I Schulman, Nicholas Namias, James Doherty, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2013
Nitrogen trifluoride global emissions estimated from updated atmospheric measurementsTim Arnold, Christina M Harth, Jens Mühle, et al.
British Journal of Haematology|May 14, 2011
Attainment of complete/very good partial response following rituximab-based therapy is an important determinant to progression-free survival, and is impacted by polymorphisms in FCGR3A in Waldenstrom macroglobulinaemiaSteven P Treon, Guang Yang, Christine Hanzis, et al.
Circulation|July 13, 2005
Molecular magnetic resonance imaging of atrial clots in a swine modelElmar Spuentrup, Bernd Fausten, Sylvia Kinzel, et al.
Environmental Pollution (Barking, Essex : 1987)|December 31, 2018
Commentary: EPA's proposed expansion of dose-response analysis is a positive step towards improving its ecological risk assessmentEvgenios Agathokleous, Alessandro Anav, Valda Araminiene, et al.
Circulation. Cardiovascular Imaging|May 8, 2012
Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathyMartin S Maron, Ethan J Rowin, David Lin, et al.
Journal of Inherited Metabolic Disease|April 5, 2001
Features of carnitine palmitoyltransferase type I deficiencyS E Olpin, J Allen, J R Bonham, et al.
Blood|July 10, 2013
A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenström macroglobulinemiaGuang Yang, Yangsheng Zhou, Xia Liu, et al.
Pageof 103

Showing results (921-930 of 1,030) with videos related to

Sort By:
Pageof 103
Drug Testing and Analysis|March 7, 2019
The chemistry and pharmacology of putative synthetic cannabinoid receptor agonist (SCRA) new psychoactive substances (NPS) 5F-PY-PICA, 5F-PY-PINACA, and their analogsSamuel D Banister, Richard C Kevin, Lewis Martin, et al.
Journal of the American College of Cardiology|April 5, 2008
Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonanceA Selcuk Adabag, Barry J Maron, Evan Appelbaum, et al.
Surgical Infections|January 26, 2006
The effect of antipyretic therapy upon outcomes in critically ill patients: a randomized, prospective studyCarl I Schulman, Nicholas Namias, James Doherty, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2013
Nitrogen trifluoride global emissions estimated from updated atmospheric measurementsTim Arnold, Christina M Harth, Jens Mühle, et al.
British Journal of Haematology|May 14, 2011
Attainment of complete/very good partial response following rituximab-based therapy is an important determinant to progression-free survival, and is impacted by polymorphisms in FCGR3A in Waldenstrom macroglobulinaemiaSteven P Treon, Guang Yang, Christine Hanzis, et al.
Circulation|July 13, 2005
Molecular magnetic resonance imaging of atrial clots in a swine modelElmar Spuentrup, Bernd Fausten, Sylvia Kinzel, et al.
Environmental Pollution (Barking, Essex : 1987)|December 31, 2018
Commentary: EPA's proposed expansion of dose-response analysis is a positive step towards improving its ecological risk assessmentEvgenios Agathokleous, Alessandro Anav, Valda Araminiene, et al.
Circulation. Cardiovascular Imaging|May 8, 2012
Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathyMartin S Maron, Ethan J Rowin, David Lin, et al.
Journal of Inherited Metabolic Disease|April 5, 2001
Features of carnitine palmitoyltransferase type I deficiencyS E Olpin, J Allen, J R Bonham, et al.
Blood|July 10, 2013
A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenström macroglobulinemiaGuang Yang, Yangsheng Zhou, Xia Liu, et al.
Pageof 103